Literature DB >> 17559577

HLA class II amino acid epitopes as susceptibility markers of sarcoidosis.

C E M Voorter1, M Amicosante, F Berretta, L Groeneveld, M Drent, E M van den Berg-Loonen.   

Abstract

Sarcoidosis is a multisystemic disorder of unknown etiology, affecting primarily the lung and characterized by epithelioid granulomas. Disease association studies showed human leukocyte antigen (HLA) class II to be related to sarcoidosis. Initially, we studied the association of sarcoidosis with DQB1, and in the present study, we evaluated all amino acid variants of the HLA-DPB1, -DQB1, -DRB1, -DRB3, -DRB4 and -DRB5 genes to identify possible polymorphisms associated with the disease. Patients and controls were typed for class II genes to the allele level by sequence-based typing. Multiple logistic regression models showed DRAla71 and DQPhe9 to be independently associated with the disease. Subdivision of patients according to their radiographic stage resulted in identification of DRArg74 as independent associated residue in the RS I group, whereas DRAla71 and DQTyr30 were associated with RS II-IV groups. Polymorphic residues specifically associated with sarcoidosis shed new light on the characteristics of sarcoidosis-triggered peptides. Overall, pocket 9 of DQ and pocket 4 of DR seem to be the most important areas involved in the association with sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559577     DOI: 10.1111/j.1399-0039.2007.00842.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  12 in total

Review 1.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

2.  Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients.

Authors:  Johan Grunewald; Boel Brynedal; Pernilla Darlington; Magnus Nisell; Kerstin Cederlund; Jan Hillert; Anders Eklund
Journal:  Respir Res       Date:  2010-02-26

3.  Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Löfgren's syndrome and other sarcoidosis.

Authors:  B Karakaya; M C Schimmelpennink; L Kocourkova; J J van der Vis; B Meek; J C Grutters; M Petrek; C H M van Moorsel
Journal:  Clin Exp Immunol       Date:  2019-01-24       Impact factor: 4.330

Review 4.  Molecular profiling in sarcoidosis.

Authors:  Nicholas K Arger; Brian O'Connor; Laura L Koth
Journal:  Curr Opin Pulm Med       Date:  2020-09       Impact factor: 3.155

5.  Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

Authors:  Hiroe Sato; Felix A Woodhead; Tariq Ahmad; Jan C Grutters; Paolo Spagnolo; Jules M M van den Bosch; Lisa A Maier; Lee S Newman; Sonoko Nagai; Takateru Izumi; Athol U Wells; Roland M du Bois; Kenneth I Welsh
Journal:  Hum Mol Genet       Date:  2010-08-03       Impact factor: 6.150

Review 6.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

7.  Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans.

Authors:  Albert M Levin; Indra Adrianto; Indrani Datta; Michael C Iannuzzi; Sheri Trudeau; Jia Li; Wonder P Drake; Courtney G Montgomery; Benjamin A Rybicki
Journal:  Am J Respir Cell Mol Biol       Date:  2015-08       Impact factor: 6.914

8.  More immune dysregulation: Sarcoidosis and chronic graft-versus-host disease after allogeneic stem cell transplant.

Authors:  Iviensan F Manalo; India Ashton Miller; Loretta S Davis
Journal:  JAAD Case Rep       Date:  2016-03-15

Review 9.  Genetic testing in diffuse parenchymal lung disease.

Authors:  Paolo Spagnolo; Fabrizio Luppi; Stefania Cerri; Luca Richeldi
Journal:  Orphanet J Rare Dis       Date:  2012-10-17       Impact factor: 4.123

10.  Worldwide population distribution of the common LCE3C-LCE3B deletion associated with psoriasis and other autoimmune disorders.

Authors:  Laia Bassaganyas; Eva Riveira-Muñoz; Manel García-Aragonés; Juan R González; Mario Cáceres; Lluís Armengol; Xavier Estivill
Journal:  BMC Genomics       Date:  2013-04-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.